» Authors » Maximillian N J Woodall

Maximillian N J Woodall

Explore the profile of Maximillian N J Woodall including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 42
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lindeboom R, Worlock K, Dratva L, Yoshida M, Scobie D, Wagstaffe H, et al.
Nature . 2024 Aug; 632(8025):E3. PMID: 39090314
No abstract available.
2.
Lindeboom R, Worlock K, Dratva L, Yoshida M, Scobie D, Wagstaffe H, et al.
Nature . 2024 Jun; 631(8019):189-198. PMID: 38898278
The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited. Here in our SARS-CoV-2 human challenge...
3.
Woodall M, Cujba A, Worlock K, Case K, Masonou T, Yoshida M, et al.
Nat Microbiol . 2024 Jun; 9(11):3076. PMID: 38890492
No abstract available.
4.
Woodall M, Cujba A, Worlock K, Case K, Masonou T, Yoshida M, et al.
Nat Microbiol . 2024 Apr; 9(5):1293-1311. PMID: 38622380
Children infected with SARS-CoV-2 rarely progress to respiratory failure. However, the risk of mortality in infected people over 85 years of age remains high. Here we investigate differences in the...
5.
Tommasini F, Benoist T, Shibuya S, Woodall M, Naldi E, Palor M, et al.
Biomaterials . 2023 Jul; 301:122203. PMID: 37515903
Lung infections are one of the leading causes of death worldwide, and this situation has been exacerbated by the emergence of COVID-19. Pre-clinical modelling of viral infections has relied on...
6.
Maughan E, Hynds R, Pennycuick A, Nigro E, Gowers K, Denais C, et al.
iScience . 2022 Nov; 25(11):105409. PMID: 36388965
The airway epithelium is a protective barrier that is maintained by the self-renewal and differentiation of basal stem cells. Increasing age is a principle risk factor for chronic lung diseases,...
7.
Woodall M, Masonou T, Case K, Smith C
J Physiol . 2021 Jul; 599(18):4255-4267. PMID: 34287894
Currently, therapeutics for COVID-19 are limited. To overcome this, it is important that we use physiologically relevant models to reproduce the pathology of infection and evaluate the efficacy of antiviral...